IBO Stock Chart & Stats
$0.44
>-$0.01(-0.81%)
At close: 4:00 PM EDT
$0.44
>-$0.01(-0.81%)
Day’s Range― - ―
52-Week Range$4.06 - $10.48
Previous Close$0.43
Volume12.80K
Average Volume (3M)22.52K
Market Cap
$36.31M
Enterprise Value$7.19T
Total Cash (Recent Filing)$10.00K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.30
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.23
Shares Outstanding8,543,679
10 Day Avg. Volume12,962
30 Day Avg. Volume22,522
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.26
Price to Sales (P/S)497.66
P/FCF Ratio-8.43
Enterprise Value/Market Cap198.08K
Enterprise Value/Revenue205.50M
Enterprise Value/Gross Profit-18.49M
Enterprise Value/Ebitda-17.94M
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Impact BioMedical, Inc. News
IBO FAQ
What was Impact BioMedical, Inc.’s price range in the past 12 months?
Impact BioMedical, Inc. lowest stock price was $4.06 and its highest was $10.48 in the past 12 months.
What is Impact BioMedical, Inc.’s market cap?
Impact BioMedical, Inc.’s market cap is $36.31M.
When is Impact BioMedical, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Impact BioMedical, Inc.’s earnings last quarter?
Currently, no data Available
Is Impact BioMedical, Inc. overvalued?
According to Wall Street analysts Impact BioMedical, Inc.’s price is currently Overvalued.
Does Impact BioMedical, Inc. pay dividends?
Impact BioMedical, Inc. does not currently pay dividends.
What is Impact BioMedical, Inc.’s EPS estimate?
Impact BioMedical, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Impact BioMedical, Inc. have?
Impact BioMedical, Inc. has 8,543,679 shares outstanding.
What happened to Impact BioMedical, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Impact BioMedical, Inc.?
Currently, no hedge funds are holding shares in IBO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Impact BioMedical, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.10%
12-Months-Change
Fundamentals
Return on Equity
13.70%
Trailing 12-Months
Asset Growth
-12.15%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Impact BioMedical, Inc.
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.
Technical Analysis
Ownership Overview
11.64% Insiders
9.33% Mutual Funds
― Other Institutional Investors
68.38% Public Companies and
Individual Investors